TIE1 and cervical carcinoma: Recently, the angiopoietin (Ang)/tyrosine kinase receptor (Tie) system, the second largest angiogenic system after vascular endothelial growth factor; (VEGF), has attracted increasing attention because targeting VEGF has demonstrated limited efficacy in cervical cancer detection and monitoring [3].